
Stallion India Fluorochemicals reported a 27.43% decline in standalone net sales to Rs 109.99 crore and a 17.6% decrease in quarterly net profit to Rs 10.93 crore for March 2026 compared to the same quarter in 2025. EBITDA also fell by 13.14% to Rs 17.65 crore, with EPS dropping to Rs 1.33. However, the full-year results showed a 14.1% increase in sales to Rs 430.68 crore and a 35.6% rise in net profit to Rs 43.84 crore for the year ended March 2026.
The articles focus on financial performance without political framing, presenting factual quarterly and annual results. Both sources provide consistent data on sales and profit changes, reflecting a business-centric perspective without political commentary or partisan viewpoints.
The overall tone is neutral to mixed, highlighting declines in quarterly sales and profits alongside positive full-year growth. The coverage balances negative short-term results with longer-term improvements, avoiding emotive language and maintaining an objective financial reporting style.
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.
| Source | Their headline | Bias | Sentiment |
|---|---|---|---|
| businessstandard | Stallion India tumbles after Q4 PAT slides 18 YoY to Rs 11 cr | Center | Neutral |
| businessstandard | Stallion India Fluorochemicals standalone net profit declines 17.63 in the March 2026 quarter | Center | Neutral |
| moneycontrol | Stallion India Standalone March 2026 Net Sales at Rs 109.99 crore, down 27.43 Y-o-Y- Moneycontrol.com | Center | Negative |
moneycontrol broke this story on 13 May, 09:08 am. Other outlets followed.
Well-covered story — coverage matches public importance.
Institutions and figures named across source coverage.
Select a news story to see related coverage from other media outlets.